- Investing Ideas
- /
- Global Healthcare Undervalued Small Caps With Insider Buying
Global Healthcare Undervalued Small Caps With Insider Buying
Results
5
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
5 companies
CVS Group
Market Cap: UK£842.1m
Engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia.
CVSG
UK£11.80
7D
4.4%
1Y
43.4%
Integra LifeSciences Holdings
Market Cap: US$937.8m
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$12.45
7D
6.1%
1Y
-48.6%
Cogstate
Market Cap: AU$444.5m
A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.
CGS
AU$2.59
7D
-4.1%
1Y
169.8%
Omda
Market Cap: NOK 963.9m
Provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally.
OMDA
NOK 47.00
7D
-1.7%
1Y
66.7%
Vimian Group
Market Cap: SEK 15.5b
Engages in the animal health business worldwide.
VIMIAN
SEK 29.40
7D
-4.2%
1Y
-34.5%